BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28541748)

  • 1. Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer.
    Gould MK; Munoz-Plaza CE; Hahn EE; Lee JS; Parry C; Shen E
    Ann Am Thorac Soc; 2017 Oct; 14(10):1571-1580. PubMed ID: 28541748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Comorbidity Profiles and Their Effect on Treatment and Survival in Patients With Colorectal Cancer.
    Hahn EE; Gould MK; Munoz-Plaza CE; Lee JS; Parry C; Shen E
    J Natl Compr Canc Netw; 2018 Jan; 16(1):23-34. PubMed ID: 29295878
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
    Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
    Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study.
    Nilsson J; Berglund A; Bergström S; Bergqvist M; Lambe M
    Acta Oncol; 2017 Jul; 56(7):949-956. PubMed ID: 28486004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients.
    Lüchtenborg M; Jakobsen E; Krasnik M; Linklater KM; Mellemgaard A; Møller H
    Eur J Cancer; 2012 Dec; 48(18):3386-95. PubMed ID: 22795582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
    Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
    Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidity measurement in patients with laryngeal squamous cell carcinoma.
    Castro MA; Dedivitis RA; Ribeiro KC
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(3):146-52. PubMed ID: 17264530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors associated with interventional bronchoscopy in lung cancer.
    Guibert N; Mazieres J; Lepage B; Plat G; Didier A; Hermant C
    Ann Thorac Surg; 2014 Jan; 97(1):253-9. PubMed ID: 24094520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
    Singh N; Singh PS; Aggarwal AN; Behera D
    Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.
    Uyterlinde W; Belderbos J; Baas C; van Werkhoven E; Knegjens J; Baas P; Smit A; Rikers C; van den Heuvel M
    Clin Lung Cancer; 2013 Sep; 14(5):541-8. PubMed ID: 23835165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
    Seigneurin A; Delafosse P; Trétarre B; Woronoff AS; Velten M; Grosclaude P; Guizard AV; Lapôtre-Ledoux B; Bara S; Molinié F; Colonna M
    BMC Cancer; 2018 Nov; 18(1):1091. PubMed ID: 30419850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
    Dalton SO; Steding-Jessen M; Jakobsen E; Mellemgaard A; Østerlind K; Schüz J; Johansen C
    Acta Oncol; 2015 May; 54(5):797-804. PubMed ID: 25761702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O; Kappetein AP; Goorden T; van Klaveren RJ; Bogers AJ
    Ann Thorac Surg; 2005 Sep; 80(3):1021-6. PubMed ID: 16122477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study.
    Clément-Duchêne C; Stock S; Xu X; Chang ET; Gomez SL; West DW; Wakelee HA; Gould MK
    Ann Am Thorac Soc; 2016 Jan; 13(1):58-66. PubMed ID: 26730864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
    Stevens W; Stevens G; Kolbe J; Cox B
    J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.